These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16787414

  • 1. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
    d'Abramo C, Ricciarelli R, Pronzato MA, Davies P.
    J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
    [Abstract] [Full Text] [Related]

  • 2. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.
    He G, Sung YM, Digiovanni J, Fischer SM.
    Cancer Res; 2006 Feb 01; 66(3):1873-8. PubMed ID: 16452250
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
    Cho DH, Lee EJ, Kwon KJ, Shin CY, Song KH, Park JH, Jo I, Han SH.
    J Neurochem; 2013 Sep 01; 126(5):685-95. PubMed ID: 23581463
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M, Lee TW, Yim AP, Mok TS, Chen GG.
    J Cell Physiol; 2006 Nov 01; 209(2):428-38. PubMed ID: 16883598
    [Abstract] [Full Text] [Related]

  • 5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J, Levy M, Dickson DW, Potter H.
    Brain; 2006 Nov 01; 129(Pt 11):3020-34. PubMed ID: 16987932
    [Abstract] [Full Text] [Related]

  • 6. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 01; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity.
    Lee KS, Park JH, Lee S, Lim HJ, Jang Y, Park HY.
    Biochem Biophys Res Commun; 2006 Jul 21; 346(1):83-8. PubMed ID: 16759638
    [Abstract] [Full Text] [Related]

  • 8. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
    Li X, Yang X, Xu Y, Jiang X, Li X, Nan F, Tang H.
    Cell Res; 2009 Jun 21; 19(6):720-32. PubMed ID: 19417774
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
    Gao M, Hu Z, Zheng Y, Zeng Y, Shen X, Zhong D, He F.
    Shock; 2011 Sep 21; 36(3):228-34. PubMed ID: 21617575
    [Abstract] [Full Text] [Related]

  • 10. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
    Baumann P, Mandl-Weber S, Emmerich B, Straka C, Schmidmaier R.
    Exp Cell Res; 2007 Oct 01; 313(16):3592-603. PubMed ID: 17669398
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.
    Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M.
    Exp Cell Res; 2005 Mar 10; 304(1):91-104. PubMed ID: 15707577
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, Chen CS.
    Cancer Res; 2007 Apr 01; 67(7):3229-38. PubMed ID: 17409431
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
    Little PJ, Ballinger ML, Survase S, Osman N, Ogru E, Geytenbeek S, Bruemmer D, Nigro J.
    J Cardiovasc Pharmacol; 2008 Mar 01; 51(3):274-9. PubMed ID: 18356692
    [Abstract] [Full Text] [Related]

  • 14. Increased tau phosphorylation at the Ser396 epitope after amyloid beta-exposure in organotypic cultures.
    Johansson S, Jämsä A, Vasänge M, Winblad B, Luthman J, Cowburn RF.
    Neuroreport; 2006 Jun 26; 17(9):907-11. PubMed ID: 16738486
    [Abstract] [Full Text] [Related]

  • 15. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y, Ping J, Xu LM.
    Chin Med J (Engl); 2007 May 05; 120(9):794-801. PubMed ID: 17531121
    [Abstract] [Full Text] [Related]

  • 16. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J, Morales M, Caelles C.
    Diabetes; 2007 Jul 05; 56(7):1865-71. PubMed ID: 17416798
    [Abstract] [Full Text] [Related]

  • 17. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA.
    Eur J Pharmacol; 2007 May 21; 562(3):247-58. PubMed ID: 17343846
    [Abstract] [Full Text] [Related]

  • 18. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J, Flament S, Salamone S, Boisbrun M, Mazerbourg S, Chapleur Y, Grillier-Vuissoz I.
    Breast Cancer Res Treat; 2008 Dec 21; 112(3):437-51. PubMed ID: 18204896
    [Abstract] [Full Text] [Related]

  • 19. Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines.
    Turturro F, Friday E, Fowler R, Surie D, Welbourne T.
    Clin Cancer Res; 2004 Oct 15; 10(20):7022-30. PubMed ID: 15501982
    [Abstract] [Full Text] [Related]

  • 20. Troglitazone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.
    Welbourne T, Friday E, Fowler R, Turturro F, Nissim I.
    Am J Physiol Renal Physiol; 2004 Jan 15; 286(1):F100-10. PubMed ID: 14506076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.